Oxford BioMedica plc

United Kingdom


Create a watch for Oxford BioMedica plc
Total IP 32
Total IP incl. subs 89 (+ 57 for subs)
Total IP Rank # 45,731
IP Activity Score 2.2/5.0    21
IP Activity Rank # 38,524
IP AS incl. subs 2.3/5.0    54
Stock Symbol
ISIN GB00BDFBVT43
Market Cap. 452.4M  (GBX)
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

0 7
0 11
0 5
9
 
Last Patent 2006 - Antibodies
First Patent 1998 - Retroviral vectors
Last Trademark 2024 - OXB
First Trademark 1997 - LENTIVECTOR

Subsidiaries

4 subsidiaries with IP (55 patents, 2 trademarks)

1 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Custom and contract manufacture of products relating to biotechnology, namely, gene therapy, and ...
G/S Custom manufacture of products relating to biotechnology; custom manufacture of gene therapy, an...
G/S Custom manufacture of products relating to biotechnology; custom manufacture of gene therapy, and...
G/S Custom manufacture of products relating to biotechnology; manufacture of gene therapy, and viral,...
G/S Custom manufacture of products relating to biotechnology; manufacture of gene and cell-based ther...
G/S Custom manufacture of products relating to biotechnology, namely, custom manufacture of biopharma...
2015 G/S [ Chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals an...
2012 G/S Research and laboratory analytic and diagnostic services; product and analytic assay development ...
2011 G/S Chemical and biochemical products for use in industry and science; antibodies; enzymes; nucleic a...
2009 G/S Chemical products for use in industry and science, namely chemicals for in-vitro use and analysis...
G/S Chemical products for use in industry and science namely gene therapy products namely genetically...
G/S Chemical products for use in industry and science; enzymes; chemical products for in-vitro use i...
G/S Chemical products for use in industry and science; enzymes; chemical products for in-vitro use in...
G/S Chemical products for use in industry and science, namely, enzymes for scientific and research pu...
2008 G/S Gene therapy and prophylaxis products, namely vaccines for the treatment or prevention of cancer;...
2007 G/S Gene therapy preparations for use in the treatment of viral and bacterial infections, cancer, HIV...
G/S Chemical products for use in industry and science for use in gene delivery technology and for the...
G/S Chemical products for use in industry and science; enzymes; chemical products for in vitro use i...
G/S Chemical products for use in industry and science in respect of gene delivery, gene transfer, enz...
G/S Chemical compositions containing nucleic acids for use in the manufacturing of pharmaceuticals an...
2006 G/S Gene therapy and prophylaxis products for the treatment of cancer; vaccines, gene therapy prophy...
2001 Invention Antibodies. The use of an ScFv Ab (ScFv Ab) capable of recognising a disease associated molecule ...
1998 Invention Retroviral vectors. Retroviral vector production systems for producing lentivirus-based vector pa...
1997 G/S Chemical products for use in industry and science; enzymes; chemical products for in vitro use in...